- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-OCIAD1
OCIAD1 Monoclonal Antibody for WB, IHC, IF/ICC, IF-P, Cytometric bead array, Indirect ELISA
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, IF-P, Cytometric bead array, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
1C10C3
N° de cat : 66698-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66698-1-PBS cible OCIAD1 dans les applications de WB, IHC, IF/ICC, IF-P, Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | OCIAD1 Protéine recombinante Ag9977 |
Nom complet | OCIA domain containing 1 |
Masse moléculaire calculée | 28 kDa |
Poids moléculaire observé | 35 kDa |
Numéro d’acquisition GenBank | BC003409 |
Symbole du gène | OCIAD1 |
Identification du gène (NCBI) | 54940 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
OCIAD1 was first identified by immunoscreening of an ovarian carcinoma cDNA expression library with ascites fluid from ovarian cancer patients (PMID: 11162530). OCIAD1 has been reported as a key player in ovarian cancer cell adhesion, as well as a key player in generating ovarian cancer recurrence (PMID: 18328549; 20515946). In addition to its roles in cancer, OCIAD1 participates in maintaining stem cell potency by regulating the Jak/STAT pathway (PMID: 23972987). Several alternatively spliced forms of OCIAD1 gene have been identified. The longest form (1.4 kb) is predicted to encode for a 27.6 kDa protein of 245 amino acids. This antibody detects OCIAD1 with an apparent molecular weight of ~35 kDa as has been demonstrated by several researches (PMID: 27345969; 27345976).